BioPharma Credit (LON:BPCR – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 1 and last traded at GBX 0.97, with a volume of 813598 shares changing hands. The stock had previously closed at GBX 0.97.
BioPharma Credit Stock Performance
The stock has a market cap of £10.86 million, a P/E ratio of 0.08 and a beta of 0.22. The firm’s 50-day simple moving average is GBX 0.96 and its 200 day simple moving average is GBX 0.94.
About BioPharma Credit
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than BioPharma Credit
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
